The identification of predictive factors for perioperative chemotherapy in esophago-gastric cancer

By Lordick F.   Rcken C.  

Annals of Oncology, Vol. 24, Iss. 5, 2013-05 ,pp. : 1135-1138

Oxford University Press

Access to resources Recommend Favorite

Level I Evidence in Support of Perioperative Chemotherapy for Operable Gastric Cancer: Sufficient for Wide Clinical Use?

By Briasoulis Evangelos  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2691-2695

Springer Publishing Company

Access to resources Recommend Favorite

Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?

By Persiani Roberto  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 1077-1079

Springer Publishing Company

Access to resources Recommend Favorite

The UK NCRI MAGIC Trial of Perioperative Chemotherapy in Resectable Gastric Cancer: Implications for Clinical Practice

By Chua Yu  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2687-2690

Springer Publishing Company

Access to resources Recommend Favorite

Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy

By Glehen Olivier  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2370-2377

Springer Publishing Company

Access to resources Recommend Favorite